693 results match your criteria: "Poroma"
Radiol Case Rep
November 2022
Department of Surgery Salah Aziez Institute, University of Sfax, Tunisia.
Eccrine poroma is a rare adult benign adnexal tumor that originates in the excretory pore of the sweat gland. It is a small reddish lesion, protuberant, fleshy, and well-defined. It is located preferably in the palms of the hands and the soles of the feet [1].
View Article and Find Full Text PDFExp Dermatol
November 2022
Dermatology Unit, Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Eccrine poroma (EP) is a rare benign adnexal tumor that may mimic benign or malignant tumors and differential diagnosis may be difficult under clinical and dermoscopic examination. Reflectance confocal microscopy (RCM) examination may add important information to diagnosis and subsequent management of solitary lesions for which dermoscopy can be challenging. The aim of the present study was to investigate features of EP at RCM in order to detect the characteristics that might aid in the differential diagnosis of EP versus other solitary lesions (benign or malignant).
View Article and Find Full Text PDFJ Dermatol
December 2022
Department of Dermatology, Kanazawa Medical University, Uchinada, Japan.
Int J Surg Case Rep
September 2022
Department of General Surgery, Kilimanjaro Christian Medical Centre, Moshi, Tanzania; Department of General Surgery, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Introduction: Porocarcinoma is a rare malignancy of dermal sweat glands commonly diagnosed in the seventh decade of life. It frequently evolves from a de novo benign poroma. These tumors present as a mass/nodule, ulcer, papule, or wart.
View Article and Find Full Text PDFActas Dermosifiliogr
February 2023
Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España. Electronic address:
Background: Poroma is a benign, exclusively cutaneous, adnexal tumor with a predilection for palmoplantar skin.
Objective: To analyze the clinical characteristics of poroma in our population.
Material And Methods: Retrospective study of patients diagnosed with poroma between 2002 and 2021.
J Cosmet Dermatol
November 2022
Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
An Bras Dermatol
August 2022
Department of Dermatology, Faculty of Medicine, Universidade Estadual Paulista, Botucatu, SP, Brazil. Electronic address:
Eccrine poroma is the term that includes benign neoplasms of the terminal duct of the eccrine sweat glands, which may clinically and dermoscopically resemble other melanoma and non-melanoma skin tumors. They are often located on the extremities (especially palms and soles), presenting as normochromic or erythematous papules and nodules, measuring up to 2 cm. Pigmented variants are uncommon, accounting for less than 20% of cases.
View Article and Find Full Text PDFJAAD Case Rep
July 2022
Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
J Cutan Pathol
October 2022
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Background: Poromas, and their malignant counterparts, porocarcinomas, harbor recurrent translocations involving YAP1-MAML2, YAP1-NUTM1, and infrequently WWTR1-NUTM1; YAP1-NUTM1 being the most common in porocarcinomas. NUT immunohistochemistry (IHC) can be used to identify NUTM1-translocated tumors. This study sought to investigate potential novel NUTM1-fusion partners among NUT IHC-positive poromas and porocarcinomas.
View Article and Find Full Text PDFDermatol Pract Concept
May 2022
Second Department of Dermatology-Venereology, Attikon General University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
Dermatol Pract Concept
May 2022
Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.
Skin Res Technol
July 2022
Department of Dermatology, The First College of Clinical Medical Sciences, China Three Gorges University, Yichang, China.
J Eur Acad Dermatol Venereol
September 2022
Centro Oncologico ad Alta Tecnologia Diagnostica, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
J Clin Med
April 2022
Department of Plastic, Reconstructive and Aesthetic Surgery, Geneva University Hospitals, University of Geneva, 1205 Geneva, Switzerland.
Unlabelled: Porocarcinoma is a rare malignant adnexal tumor. Little is known about the location of the disease in the head and neck. Our aim is to offer the largest analysis of demographic, pathological, and treatment patterns of head and neck porocarcinoma in comparison with other locations of the neoplasm from an epidemiologically representative cohort.
View Article and Find Full Text PDFPorocarcinoma is a rare type of skin cancer that develops from the intraepidermal ductal part of eccrine sweat glands. It can arise de novo or from poroma ground with high potential for locoregional metastatic spread, morbidity, and mortality. It mostly occurs in elderly patients.
View Article and Find Full Text PDFInt J Surg Pathol
December 2022
Department of Pathology and Laboratory Medicine, 22916Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
Originally described in a rare subset of poorly differentiated squamous cell carcinomas termed NUT carcinomas, rearrangements are now known to characterize a wide spectrum of neoplasms including sarcomas, poromas/porocarcinomas, unclassified adnexal carcinomas and pediatric acute lymphoblastic leukemia. The advent of next-generation sequencing (NGS) has led to the identification of a multitude of novel fusion partners in addition to , which was initially reported in the majority of NUT carcinomas. -rearranged sarcomas usually harbor fusions with the MAD gene family (, , ) and present as spindle cell proliferations in diverse locations in patients of all ages.
View Article and Find Full Text PDFSci Rep
April 2022
Department of Pathology, University of Helsinki, P.O. Box 63, 00014, Helsinki, Finland.
Eccrine porocarcinoma (EPC) is a rare malignant adnexal tumour of the skin. Part of EPCs develop from their benign counterpart, poroma (EP), with chronic light exposure and immunosuppression hypothesized to play a role in the malignant transformation. However, the impact of chronic light exposure on the microenvironment of EPCs and EPs has not been investigated yet.
View Article and Find Full Text PDFBMJ Case Rep
March 2022
Breast Unit, Champalimaud Clinical Center / Champalimaud Foundation, Lisbon, Portugal.
Eccrine porocarcinoma is a rare skin adnexal malignant neoplasm that may arise from a pre-existing benign eccrine poroma or without a predisposing factor. It is a highly invasive neoplasm and has a strong metastatic potential. The most frequently affected organs are the lymph nodes and rarely solid organs such as the liver, lungs and breast.
View Article and Find Full Text PDFDermatopathology (Basel)
January 2022
Center for Clinical Studies, Webster, TX 77598, USA.
Poromas or poroid tumors are a group of rare, benign cutaneous neoplasms derived from the terminal eccrine or apocrine sweat gland duct. There are four poroma variants with overlapping features: dermal duct tumor (DDT), eccrine poroma, hidroacanthoma simplex, and poroid hidradenoma, of which DDT is the least common. Clinically, the variants have a nonspecific appearance and present as solitary dome-shaped papules, plaques, or nodules.
View Article and Find Full Text PDFGenes Chromosomes Cancer
May 2022
Pathologisches Institut, Universitätsklinikum Erlangen, Erlangen, Germany.
Gene fusions have been increasingly identified as central events driving oncogenesis in a variety of benign and malignant neoplasms of different histogenesis originating in diverse organs. While some fusion-driven neoplasms may occur at any body site, certain genotypes and their associated phenotypic entities cluster to specific body site/organ, albeit with variable frequencies among anatomic locations. In the last two decades, several skin adnexal entities driven by specific fusions have been described; some of them represent new entities (eg, secretory carcinoma harboring NTRK fusions), while others are old established entities with newly discovered underlying gene fusions (eg, poroid neoplasms harboring NUTM1, YAP1, and WWTR1 fusions).
View Article and Find Full Text PDFJ Cutan Pathol
June 2022
Department of Dermatology, Nara Medical University School of Medicine, Kashihara, Japan.
Background: Cysts of the skin are observed frequently and their diagnoses are generally straightforward. However, atypical cystic lesions for which differentiation is indistinct have been noted.
Methods: We examined five cases of trichilemmal cyst with proteinaceous material (TCPM), which required differentiation from sweat duct/gland tumors.
Cancers (Basel)
January 2022
French Network of Rare Skin Cancers, CARADERM, France.
Am J Dermatopathol
May 2022
Departments of Dermatology and Pathology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA.
A 76-year-old female patient presented with a peculiar new exophytic-appearing, flesh-colored skin lesion on her left hallux. Owing to its atypical appearance, the neoplasm was biopsied. Histologic sections demonstrated numerous thickened, anastomosing cord-like structures composed of bland appearing adnexal keratinocytes attached to the epidermis and extending into the superficial dermis.
View Article and Find Full Text PDFSkin Appendage Disord
January 2022
Dermatology & Surgery Clinic, Singapore, Singapore.
Eccrine porocarcinomas (EPCs) are rare tumours, albeit the most common malignant adnexal tumours of the skin. They can present with very heterogeneous clinical and dermoscopic features, rendering diagnosis limited to histopathological examination alone. We share 2 cases of EPCs, one of which arose in a patient with a prior diagnosis of cutaneous squamous cell carcinoma (SCC) and another whose EPC was likely a malignant transformation of an existing poroma.
View Article and Find Full Text PDFCureus
November 2021
Hematology and Oncology, Cape Fear Valley Medical Center, Fayetteville, USA.
Eccrine porocarcinoma (EPC) is a rare malignancy of the sweat glands. Currently, there is no standard algorithm for its presentations, diagnosis, and management. However, immunotherapy is an emerging option that may be crucial to the treatment of EPC.
View Article and Find Full Text PDF